Synergistic enhancement of chemokine generation and lung injury by C5a or the membrane attack complex of complement.
暂无分享,去创建一个
A. Lentsch | P. Ward | H. Schmal | B. Czermak | N. Bless | H. Friedl | Hagen Schmal | Peter A. Ward | Hans P. Friedl
[1] S. Rennard,et al. Expression of receptors for C5a anaphylatoxin (CD88) on human bronchial epithelial cells: enhancement of C5a-mediated release of IL-8 upon exposure to cigarette smoke. , 1998, Journal of immunology.
[2] A. Lentsch,et al. NF-kappaB activation during IgG immune complex-induced lung injury: requirements for TNF-alpha and IL-1beta but not complement. , 1998, The American journal of pathology.
[3] C. Mold. Cellular Responses to the Membrane Attack Complex , 1998 .
[4] A. Lentsch,et al. In vivo suppression of NF-kappa B and preservation of I kappa B alpha by interleukin-10 and interleukin-13. , 1997, The Journal of clinical investigation.
[5] K. Laupland,et al. Neonatal activation of CD28 signaling overcomes T cell anergy and prevents autoimmune diabetes by an IL-4-dependent mechanism. , 1997, The Journal of clinical investigation.
[6] P. Ward,et al. Sublytic concentrations of the membrane attack complex of complement induce endothelial interleukin-8 and monocyte chemoattractant protein-1 through nuclear factor-kappa B activation. , 1997, The American journal of pathology.
[7] P. Ward,et al. Requirement for C-X-C chemokines (macrophage inflammatory protein-2 and cytokine-induced neutrophil chemoattractant) in IgG immune complex-induced lung injury. , 1997, Journal of immunology.
[8] P. Ward,et al. C5a-dependent up-regulation in vivo of lung vascular P-selectin. , 1997, Journal of immunology.
[9] P. Ward,et al. Rous-Whipple Award Lecture. Role of complement in lung inflammatory injury. , 1996, The American journal of pathology.
[10] J. Christman,et al. In vivo antioxidant treatment suppresses nuclear factor-kappa B activation and neutrophilic lung inflammation. , 1996, Journal of immunology.
[11] P. Ward,et al. Requirement and role of C5a in acute lung inflammatory injury in rats. , 1996, The Journal of clinical investigation.
[12] P. Ward,et al. Enhancement by the complement membrane attack complex of tumor necrosis factor-alpha-induced endothelial cell expression of E-selectin and ICAM-1. , 1995, Journal of immunology.
[13] P. Ward,et al. Lung sources and cytokine requirements for in vivo expression of inducible nitric oxide synthase. , 1995, American journal of respiratory cell and molecular biology.
[14] P. Ward,et al. Role of macrophage inflammatory protein-1 alpha (MIP-1 alpha) in acute lung injury in rats. , 1995, Journal of immunology.
[15] R. Wetsel. Expression of the complement C5a anaphylatoxin receptor (C5aR) on non-myeloid cells. , 1995, Immunology letters.
[16] P. Ward,et al. C5a-induced expression of P-selectin in endothelial cells. , 1994, The Journal of clinical investigation.
[17] J. Ravetch,et al. Fc receptors initiate the Arthus reaction: redefining the inflammatory cascade. , 1994, Science.
[18] T. Hugli,et al. Primary structure and functional characterization of rat C5a: An anaphylatoxin with unusually high potency , 1994, Protein science : a publication of the Protein Society.
[19] F. Gannon,et al. A one-hour minipreparation technique for extraction of DNA-binding proteins from animal tissues. , 1994, BioTechniques.
[20] J. Hiscott,et al. Characterization of a functional NF-kappa B site in the human interleukin 1 beta promoter: evidence for a positive autoregulatory loop , 1993, Molecular and cellular biology.
[21] M. Plumb,et al. C/EBP, NF-kappa B, and c-Ets family members and transcriptional regulation of the cell-specific and inducible macrophage inflammatory protein 1 alpha immediate-early gene , 1993, Molecular and cellular biology.
[22] T. Standiford,et al. MCP-1 expression by rat type II alveolar epithelial cells in primary culture. , 1993, Journal of immunology.
[23] R. Takigiku,et al. Macrophage inflammatory proteins 1 and 2: expression by rat alveolar macrophages, fibroblasts, and epithelial cells and in rat lung after mineral dust exposure. , 1993, American journal of respiratory cell and molecular biology.
[24] Cullen B. Owens,et al. Superoxide responses of endothelial cells to C5a and TNF-alpha: divergent signal transduction pathways. , 1992, The American journal of physiology.
[25] B. Zimmermann,et al. Activation of the fifth component of human complement, C5, without cleavage, by methionine oxidizing agents. , 1992, Molecular immunology.
[26] M. Frank,et al. The role of complement in inflammation and phagocytosis. , 1991, Immunology today.
[27] S. Murakami,et al. Hepatitis B virus X protein transactivates human interleukin-8 gene through acting on nuclear factor kB and CCAAT/enhancer-binding protein-like cis-elements. , 1991, The Journal of biological chemistry.
[28] K. Matsushima,et al. Cooperative interaction of nuclear factor-kappa B- and cis-regulatory enhancer binding protein-like factor binding elements in activating the interleukin-8 gene by pro-inflammatory cytokines. , 1990, The Journal of biological chemistry.
[29] H. Hohmann,et al. Tumor necrosis factors-alpha and -beta bind to the same two types of tumor necrosis factor receptors and maximally activate the transcription factor NF-kappa B at low receptor occupancy and within minutes after receptor binding. , 1990, The Journal of biological chemistry.
[30] B. Morgan. Complement membrane attack on nucleated cells: resistance, recovery and non-lethal effects. , 1989, The Biochemical journal.
[31] P. Sims,et al. Complement proteins C5b-9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. , 1989, The Journal of biological chemistry.
[32] M. Gawryl,et al. Accentuated formation of the terminal C5b-9 complement complex in patient plasma precedes development of the adult respiratory distress syndrome. , 1988, The American review of respiratory disease.
[33] J. Weigelt,et al. Complement and the severity of pulmonary failure. , 1988, The Journal of trauma.
[34] T. Espevik,et al. A highly sensitive cell line, WEHI 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. , 1986, Journal of immunological methods.
[35] M. Mayer,et al. The relationship between channel size and the number of C9 molecules in the C5b-9 complex. , 1985, Journal of immunology.
[36] M. Lamy,et al. Complement activation in patients at risk of developing the adult respiratory distress syndrome. , 1984, The American review of respiratory disease.
[37] J. Monahan,et al. Measurement of the ratio of the eighth and ninth components of human complement on complement-lysed membranes. , 1984, Biochemistry.
[38] G. Larsen,et al. Complement fragments, alveolar macrophages, and alveolitis. , 1979, The American journal of pathology.
[39] P. Ward,et al. Acute immunologic pulmonary alveolitis. , 1974, The Journal of clinical investigation.
[40] A. Lentsch,et al. In Vivo Suppression of NFk B and Preservation of I k B a by Interleukin-10 and Interleukin-13 , 1997 .
[41] T. Lint,et al. Accentuated complement activation in patient plasma during the adult respiratory distress syndrome: a potential mechanism for pulmonary inflammation. , 1989, Heart & lung : the journal of critical care.
[42] M. Betz,et al. Effect of the late complement components C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. , 1987, International archives of allergy and applied immunology.
[43] P. Craddock. Complement, granulocytes, and shock lung. , 1984, The American journal of emergency medicine.
[44] J. Hiscott,et al. Characterization of a Functional NF-KdB Site in the Human Interleukin 13 Promoter: Evidence for a Positive Autoregulatory Loop , 2022 .
[45] M. Grove,et al. C/EBP, NF-vB, and c-Ets Family Members and Transcriptional Regulation of the Cell-Specific and Inducible Macrophage Inflammatory Protein lot Immediate-Early Gene , 2022 .